Nine Chapters Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Nine Chapters Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,900	Closed	-$203K	–	330
2016 Q4	$203K	Buy	+6,900	New	+$210K	0.34%	115
2015 Q4	–	Sell	-13,100	Closed	-$277K	–	740
2015 Q3	$277K	Sell	13,100 -6,200	-32%	-$160K	0.02%	745
2015 Q2	$536K	Buy	19,300 +7,900	+69%	+$223K	0.05%	548
2015 Q1	$348K	Buy	+11,400	New	+$362K	0.03%	687
2014 Q4	–	Sell	-7,300	Closed	-$207K	–	1271
2014 Q3	$207K	Buy	+7,300	New	+$204K	0.02%	841
2014 Q1	–	Sell	-28,800	Closed	-$843K	–	1020
2013 Q4	$843K	Buy	+28,800	New	+$914K	0.08%	336

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nine Chapters Capital Management's GHDX Position: Q1 2017 in Review

Nine Chapters Capital Management sold out of Genomic Health, Inc. (GHDX) in Q1 2017, closing a stake of 6,900 shares — an estimated $203K sold.

Nine Chapters Capital Management first reported a position in GHDX in Q4 2013 and held it in 6 quarters. The position peaked at $843K in Q4 2013. 124 funds tracked by Wall St. Rank hold GHDX as of Q1 2017.

Nine Chapters Capital Management reported no remaining Genomic Health, Inc. position as of Q1 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 6,900 Genomic Health, Inc. shares in Q1 2017, an estimated $203K.
Nine Chapters Capital Management first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 6 quarters.
Nine Chapters Capital Management's Genomic Health, Inc. position peaked at $843K in Q4 2013.
124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2017.

Based on Nine Chapters Capital Management's 13F filing for Q1 2017, filed 8 May 2017.